"Never doubt that a small group of thoughtful, committed citizens can change the world. Indeed, it is the only thing that ever has."

Margaret Mead

Original article

Aspiration Thrombectomy Versus Stent Retriever Thrombectomy Alone for Acute Ischemic Stroke: A Systematic Review and Meta-Analysis



This meta-analysis was conducted to assess the safety and efficacy of aspiration thrombectomy versus stent retriever thrombectomy for acute ischemic stroke (AIS).


We queried online databases for original studies comparing aspiration thrombectomy with stent retriever thrombectomy in patients with AIS. After article selection, data were extracted on multiple baseline characteristics and prespecified endpoints. Dichotomous data were presented as risk ratios (RRs) and corresponding 95% confidence intervals (CIs); continuous data as mean differences and 95% CIs. The data were pooled using a random-effects model. Subgroup analysis was conducted based on study type, site of occlusion, and age.


We shortlisted nine relevant studies (n=1453 patients; n=690 receiving aspiration thrombectomy and n=763 receiving stent retriever thrombectomy). Meta-analysis demonstrated no significant difference between the two groups in the rates of successful recanalization (RR: 0.96 [0.87, 1.06]; p=0.42), excellent functional outcome (RR: 0.90 [0.80, 1.01]; p=0.06), or procedure time (weighted mean difference (WMD): -5.39 minutes [-11.81, 1.04]; p=0.10). However, when removing the study by Nishi et al., sensitivity analysis resulted in a significant reduction in procedure time with aspiration (WMD: -11.01 [-15.54, -6.49]; p<0.0001). No significant difference was observed in safety outcomes, including all-cause mortality (RR: 0.82 [0.57, 1.19]; p=0.30), intracranial hemorrhage (RR: 0.93 [0.55, 1.59]; p=0.80), symptomatic intracranial hemorrhage (RR: 0.72[0.42, 1.21]; p=0.57), or embolization to new territory (RR: 0.71 [0.42, 1.19]; p=0.19). Subgroup analysis revealed that aspiration thrombectomy led to significantly better outcomes in patients with a mean age ≤65 (RR: 1.15 [1.03, 1.29]; p=0.001), and stent retriever thrombectomy led to increased recanalization success in patients with a mean age >65 (RR: 0.89 [0.80, 1.00]; p=0.05).


Our updated meta-analysis reveals that both aspiration and stent retriever thrombectomy are comparably effective in the management of AIS. Shorter procedure times may potentially be attained with aspiration thrombectomy, and outcomes with each procedure may be age-dependent.


The American Heart Association (AHA) recommends mechanical thrombectomy for acute ischemic stroke (AIS) in patients presenting within six hours of symptom onset and considers it reasonable for selected patients presenting as long as 16-24 hours following stroke onset [1]. It also specifies that stent retrievers should remain the first choice for thrombectomy due to its exceptional functional outcomes, although instrumentation complications, such as dissections and vasospasm, have been reported. Another procedure known as ‘A Direct Aspiration First Pass Technique’ (ADAPT) has gained recognition as an alternative approach that can potentially improve outcomes over stent retriever thrombectomy alone [2-4].

ADAPT (henceforth referred to as ‘aspiration thrombectomy’) involves the suction-assisted removal of a thrombus by the largest catheter that can be reasonably placed within the target vessel and permits stent retriever salvage utilization in case of aspiration failure. Studies comparing aspiration with stent retriever thrombectomy have yielded conflicting findings [5-9]. This meta-analysis aims to resolve the inconsistencies between individual studies and provide a holistic, well-powered assessment of the safety and efficacy of aspiration thrombectomy in comparison to stent retriever thrombectomy. Additionally, we conducted a range of subgroup analyses to assess whether findings differed according to patient demographics.

Materials & Methods

This meta-analysis conforms to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) and Cochrane guidelines [10-11]. PubMed, Cochrane CENTRAL, and Scopus were searched in May 2019 without time or language restrictions. The string of keywords used for the literature search and the search strategy has been shown in Table 1.

Database Search Strategy Results
Pubmed (Acute[All Fields] AND ("ischemia"[MeSH Terms] OR "ischemia"[All Fields] OR "ischemic"[All Fields]) AND ("stroke"[MeSH Terms] OR "stroke"[All Fields])) OR AIS[All Fields] AND ("thrombectomy"[MeSH Terms] OR "thrombectomy"[All Fields] OR ("aspiration"[All Fields] AND "thrombectomy"[All Fields]) OR "aspiration thrombectomy"[All Fields]) OR ADAPT[All Fields] AND (("stents"[MeSH Terms] OR "stents"[All Fields] OR "stent"[All Fields]) AND retriever[All Fields]) OR solitaire[All Fields] OR Trevo[All Fields] 1022
Cochrane Acute ischemic stroke OR AIS AND aspiration thrombectomy OR ADAPT AND stent retriever OR solitaire OR Trevo 242
Scopus ( ( TITLE-ABS-KEY ( acute AND ischemic AND stroke ) OR TITLE-ABS-KEY ( ais ) ) ) AND ( ( TITLE-ABS-KEY ( aspiration AND thrombectomy ) OR TITLE-ABS-KEY ( adapt ) ) ) AND ( ( TITLE-ABS-KEY ( stent AND retriever ) OR TITLE-ABS-KEY ( merci ) ) ) 179

Studies were included if they: (a) were either randomized controlled trials (RCTs) or cohort studies; (b) directly compared the effects of aspiration thrombectomy with stent retriever thrombectomy alone; (c) included adult patients with AIS due to large-vessel occlusion. Two independent investigators (MM and MZ) conducted the review, and a third investigator (RSM) was consulted for discrepancies. Articles were first screened based on title and abstract and then full text.

From the studies obtained, the following efficacy outcomes were extracted: (a) successful recanalization (defined angiographically as a modified Thrombolysis in Cerebral Infarction (mTICI) score of 2b/3 on the completion angiogram obtained at the end of the index procedure); and (b) excellent functional clinical outcome (defined as a modified Rankin Scale (mRS) score of 0-1 or 0-2 after 90 days). Additionally, the following safety outcomes were extracted: (a) all-cause mortality; (b) intracranial hemorrhage (ICH); (c) symptomatic ICH (sICH); and (d) embolization to new territory (ENT). Quality assessment of included RCTs and observational studies was assessed using the Cochrane Collaboration Risk of Bias Tool (Table 2) and the Newcastle Ottawa scale (Table 3), respectively [12-13].

  Lapergue, 2017 [7] Turk III, 2019 [8]
Random generation sequence Low risk of bias Low risk of bias
Allocation concealment Low risk of bias Low risk of bias
Blinding Low risk of bias Low risk of bias
Incomplete outcome data Low risk of bias Low risk of bias
Selective reporting Low risk of bias Low risk of bias
Other bias Low risk of bias Low risk of bias
  Lapergue, 2016 [5] Mokin, 2017 [14] Mokin, 2016 [15] Stapleton, 2017 [9] Gerber, 2017 [6] Maegerlein, 2017 [16] Nishi, 2018 [17]
Exposed cohort 1 1 1 1 1 1 1
Non-exposed cohort 1 1 1 1 1 1 1
Ascertainment of Exposure 1 1 1 1 1 1 1
Outcome of interest 1 1 1 1 1 1 1
Comparability 2 2 2 2 2 2 2
Assessment of outcome 1 1 1 1 1 1 1
Length of follow-up 1 1 1 1 1 1 1
Adequacy of follow-up 1 1 1 1 1 1 1
Total score 9* 9* 9* 9* 9* 9* 9*

All statistical analyses were carried out on Review Manager V.5.3. Dichotomous data were pooled using a random-effects model and presented as risk ratios (RR) with 95% confidence intervals (CI). For continuous data, means and standard deviations were used. Mean differences and 95% CIs were calculated for each study and pooled to derive the weighted mean difference (WMD) and corresponding 95% CI. The chi-square test was used to analyze the differences between subgroups based on the stratification of studies according to study type (RCTs vs. observational studies), site of occlusion (anterior circulation vs. posterior circulation), and age (>65 years and ≤65 years). Sensitivity analysis was conducted for all outcomes by removing each study to check if any individual study had a disproportionate effect on the results. Visual inspection of the funnel plot was used to assess publication bias. The I2 statistic was used to evaluate heterogeneity, and a value >75% was considered significant heterogeneity [18]. p-value ≤0.05 was considered significant.


Using the prespecified search strategy, our initial search retrieved 1443 studies. After exclusion, nine studies (two RCTs and seven observational studies) remained for the analysis. The PRISMA flow chart (Figure 1) outlines our literature search. These nine studies included 1453 AIS cases (n=690 in the aspiration thrombectomy arm and n=763 in the stent retriever thrombectomy arm). Baseline characteristics of studies and participants are presented in Table 4.

Study, Year Study design Study period Location of occlusion No of AP/(AP + SR) Mean age, years Men, no. (%) NIHSS, mean ASPECT, median Inclusion criteria Exclusion criteria Efficacy outcomes Safety outcomes
Lapergue et al, 2017 [7] RCT Oct 2015 - Oct 2016 AC (ICA, M1, M2) 192/381 69.9 207 (54.3) 16.2 7 1-Adults. 2-Imaging evidence of occlusion of the internal carotid. 3-M1 or M2 branches of the middle cerebral artery. 1-cerebral infarction of the posterior circulation. 2- occlusion of the cervical carotid artery. 3- prestrokemRS score >3. 1- Successful revascularization: mTICI score of 2b/3 on angiogram. 2- 90-day mRS score of 2 or less. 3- Change in NIHSS score at 24 hours. 1- Death at 90 days. 2- ICH at 24 hours. 3- sICH at 24 hours. 4- procedure-related adverse events.
Lapergue et al, 2016 [5] OS Nov 2012 - June 2014 AC (ICA, M1) 124/243 64.9 116 (47.7) 17 9 1- Proximal middle cerebral artery occlusion. 2- intracranial internal carotid artery occlusion. 3-Patients were eligible if they were treatable by MT within 6 hours of stroke onset, with bridging therapy (previous IV rtPA) or stand-alone thrombectomy.  1-Patients referred for acute ischemic stroke with cervical internal carotid occlusion/critical stenosis and basilar occlusion. 1- Successful recanalization defined angiographically as mTICI2b–3 on the angiogram at the end of the procedure. 2- mRS 0-2 at 90 days. 3- Early neurological improvement NIHSS score at 24 hours. 1- 90 days all cause mortality, 2- ENT. 3- sICH. 4- time: onset symptom to max mTICI score.
Mokin et al, 2017 [14] OS Mar 2012 - Mar 2016 AC (M2) 51/113 67 68 (58.1) 15 9 1- Treatment of patients within 24 h of stroke onset. 2- Isolated M2 occlusion. 1-Combined M1 and M2 occlusion and a tandem separate occlusion at a more proximal location (such as cervical ICA or ICA terminus occlusion). 2- strokes with an ischemic core of more than one-third of the MCA territory. 1- Successful recanalization: TICI score of 2b-3 and excellent recanalization was TICI 3. 2- 90 days mRS score of ≤2. 1- 3-months mortality. 2- parenchymal hematomas.
Mokin et al, 2016 [15] OS Mar 2012 - Jul 2015 PC 42/100 63.5 67 (67.0) 19.2 NA  1-Posterior circulation strokes. 1-Large brain stem strokes. 1- Successful recanalization: TICI score of 2b/3. 2- 90 days mRS score of ≤2. 1- ICH.
Stapleton et al, 2017 [9] OS Jun 2012 - Oct 2015 AC (NA) 47/117 67 61 (62.9) 16.5 8 1- Time from stroke onset or last seen well to groin puncture of less than 8 hours. 2- No acute hemorrhage. 3- occlusion of the terminal internal carotid artery (ICA) or middle cerebral artery (MCA) on CTA. 4- NIHSS score of 8 or higher. 5- Infarct volume <100 ml and/or ASPECTS > 4. 6- Baseline mRS score of 3 or less. 7- life expectancy greater than 6 months. 8-anatomy permitting catheterization of the intracranial vessels. 1- Patients with posterior circulation occlusions. 2- Patients with failed primary stentriever thrombectomy followed by successful aspiration thrombectomy. 1- Successful reperfusion was defined as a TICI score of 2b/3. 2- 90-day mRS score. 3- 7-day NIHSS score. 1- Death. 2- ICH. 3- sICH.
Gerber et al, 2017 [6] OS Jan 2013 - Apr 2016 PC 20/33 63 22 (67.0) 22 7  1- Presence of a BAO or an occlusion of the intracranial vertebral artery (ICVA, V4-segment) leading to a BAO. 2-EVT with SRT or AT. 1- Patients that required additional intracranial angioplasty or a permanent stent. 1- Successful recanalization: AOL 2 and 3. 1- Death. 2- ENT. 3- ICH. 4- hemorrhagic infarction. 5- parenchymatous hematoma.
Maegerlein et al, 2017 [16] OS Jun 2014 - Mar 2016 AC (ICA, MCA, ACA) + PC 36/97 74.5 52 (53.6) NA NA 1- Exclusive usage of either the ADAPT or the stent retriever technique. 2- Patients that had been treated by mechanical thrombectomy due to distal internal carotid artery (ICA)/carotid-T, middle cerebral artery (MCA), anterior cerebral artery (ACA), basilar artery (BA) occlusion. 1-Tandem occlusions 2-More than 1 clot. 3-Both procedures used. 4-Intracranial stenosis. 1- TICI scores after opening POS and after rescue maneuvers. 2- mRS scores at 90 days and at discharge. 1- Death. 2- ENT. 3- sICH. 4- Subarachnoid hemorrhage.
Nishi et al, 2018 [17] OS Sep 2014 - Mar 2015 AC + PC 44/89 75 60 (60.6) 18 NA 1-Tandem occlusions 1-Anterior circulation stroke and ASPECTS less than 5 and hemorrhagic infarction. 2-NIHSS score less than 4. 3-Time from symptom onset was more than 8 hours were excluded, except for those with wake-up stroke. 1- 90 days mRS score 0-2. 2- mTICI score 2b/3. 1- sICH
Turk III et al, 2019 [8] RCT Jun 2015 - Jul 2017 AC (ICA, MCA M1) 134/270 71.4 125 (46.3) 16.9 8 1- Age 18 and older. 2- NIHSS ≥8 at the time of neuroimaging 3- Patient Presenting within 6 hours of AIS from AC large-vessel occlusion. 4- Neuroimaging demonstrates large vessel proximal occlusion (distal ICA through MCA bifurcation) 5- Pre-event Modified Rankin Scale score 0-1. 1- Presence of an existing or pre-existing large territory infarction. 2- Known or suspected pre-existing (chronic) large vessel occlusion in the symptomatic territory. 3- Absent femoral pulses. 4- Excessive vascular access tortuosity. 5- Pregnancy. 6- Severe contrast allergy or absolute contraindication to iodinated contrast. 7-Chronic intracranial occlusion. 8- The patient has severe or fatal comorbidities. 1- 90 days mRS score 0-2. 2- mTICI score 2b/3. 3- changes in NIHSS score (24 hours, 1 week). 1- 90 days all cause mortality. 2- sICH. 3- ICH. 4- ENT and other clinically significant complications.

Our pooled analysis shows no significant difference between the aspiration group and the stent retriever group in efficacy outcomes: (a) successful recanalization (TICI 2b/3 at final angiogram) (RR: 0.96 [0.87, 1.06]; p=0.42; I2=69%); and (b) excellent functional outcome (RR: 0.90 [0.80, 1.01]; p=0.06; I2=0%). Similarly, there were no significant differences between the groups in the incidence of adverse outcomes, i.e.: (a) all-cause mortality (RR: 0.82[0.57, 1.19]; p=0.30; I2=42%); (b) ICH (RR: 0.93[0.55, 1.59]; p=0.80; I2=49%); (c) sICH (RR: 6 0.72[0.42, 1.21]; p=0.57; I2=0%), and (d) ENT (RR: 0.71[0.42, 1.19]; p=0.19; I2=0%). No significant difference in procedural time was appreciated between the two groups (WMD: -5.39 minutes [-11.81, 1.04]; p=0.10; I2=0%). However, results became significant by removing the study by Nishi et al. during the sensitivity analysis and favored the aspiration group (WMD: -11.01 [-15.54, -6.49]; p<0.0001; I2=44.3%) (Figure 2). Apart from this finding, the sensitivity analysis did not reveal any study that had a disproportionate effect on any outcome.

Subgroup analyses demonstrated no significant difference between any of the tested subgroups, with the following exception: aspiration thrombectomy led to significantly higher rates of successful recanalization in patients with a mean age ≤65 years (RR: 1.15 [1.03, 1.29]; p=0.001; I2=0%) while stent retriever thrombectomy led to increased recanalization success in patients >65 years of age (RR: 0.89 [0.80, 1.00]; p=0.05; I2=70%) (p-interaction=0.002). Table 5 and Table 6 show the results of the subgroup analysis of efficacy and safety outcomes, respectively.

  Successful recanalization Functional outcome after 90 days
RR (95% CI) p-value I2 RR (95% CI) p-value I2
1. Type of study
RCTs 1.01 (0.95, 1.07) 0.34 0 0.97 (0.82, 1.13) 0.16 48.3
Observational 0.92 (0.78, 1.10) 0.82 (0.69, 0.97)
2. Site of occlusion
AC 0.95 (0.84, 1.09) 0.20 39.3 0.90 (0.79, 1.03) 0.94 0
PC 1.10 (0.92, 1.31) 0.92 (0.53, 1.59)
3. Age
≤65 years 1.15 (1.03, 1.29) 0.002 90 0.93 (0.74, 1.16) 0.60 0
>65 years 0.89 (0.80, 1.00) 0.86 (0.72, 1.02)
  All-cause mortality ICH sICH ENT
RR (95% CI) p-value I2 RR (95% CI) p-value I2 RR (95% CI) p-value I2 RR (95% CI) p-value I2
1. Type of study
RCTs 1.01 (0.74, 1.37) 0.14 53.4 1.03 (0.83, 1.28) 0.72 0 1.00 (0.52, 1.94) 0.1 63.4 0.88 (0.31, 2.54) 0.63 0
Observational 0.55 (0.26, 1.16) 0.80 (0.21, 3.11) 0.40 (0.17, 0.95) 0.64 (0.29, 1.40)
2. Site of occlusion
AC 0.90 (0.61, 1.33) 0.61 0 0.80 (0.40, 1.60) 0.23 31 0.74 (0.39, 1.40) NA NA 0.79 (0.45, 1.39) 0.5 0
PC 0.65 (0.20, 2.15) 1.62 (0.64, 4.10) Not estimable 0.43 (0.08, 2.25)
3. Age
≤65 1.12 (0.69, 1.82) 0.18 43.4 1.62 (0.64, 4.10) 0.23 31 0.41 (0.11, 1.55) 0.37 0 0.71 (0.30, 1.64) 0.98 0
>65 0.70 (0.42, 1.16) 0.80 (0.40, 1.60) 0.79 (0.45, 1.41) 0.72 (0.35, 1.45)


In summary, this meta-analysis demonstrated the following: (a) No significant differences exist between aspiration and stent retriever thrombectomy in achieving complete recanalization and excellent functional outcomes, as well as preventing adverse events; and (b) neither treatment was better in decreasing procedure time. However, once a sensitivity analysis was undertaken following the elimination of the study by Nishi et al., the pooled time duration of the aspiration thrombectomy was reduced by 5.62 minutes in comparison to stent retriever thrombectomy and became statistically significant. Outside of this example, results appeared robust and reliable, and outcomes were not overly influenced by any particular study. They further remained consistent during subgroup stratification, with the exception of patient age. Interestingly, patients aged over 65 years of age achieved better rates of successful recanalization with stent retrievers, whereas younger patients (≤65 years) had higher rates of recanalization with aspiration thrombectomy. The study-level nature of our meta-analysis means that this finding is exploratory and not definitive. However, the wide statistical difference between the two groups (p-interaction=0.002) strongly suggests an age-related effect, and future analyses of trials should ideally explore this association in depth.

It has been hypothesized that aspiration thrombectomy can potentially lead to better outcomes. Unlike the aspiration technique, the stent retriever technique requires passage through the clot, with a risk for clot fragmentation and distal embolization [19]. Some comparative observational lean in favor of aspiration thrombectomy, others concur with our findings and report no difference between the two interventions [5-6,14-15]. The latter studies have also support from two RCTs. The Contact Aspiration vs Stent Retriever for Successful Revascularization (ASTER) trial examined whether aspiration thrombectomy would result in superior recanalization, whereas the latest trial Comparison of Direct Aspiration versus Stent Retriever as a First Approach (COMPASS) assessed for the noninferiority of functional outcomes with aspiration compared to stent retriever thrombectomy [7-8]. Despite their differing hypotheses, ASTER and COMPASS came to similar conclusions on the comparable efficacy of the two treatments.

In contrast to our findings, a meta-analysis published prior to the COMPASS Trial concluded significantly better functional outcomes with aspiration thrombectomy [8,20]. Due to the limited amount of data availability, the authors called for further multi-center RCTs to validate the conclusion. Another meta-analysis by Primiani and colleagues used a different statistical approach to compare these interventions [21]. They conducted a single-arm, non-comparative meta-analysis of each intervention and compared the two as subgroups. This study included only the preliminary results of the COMPASS trial. Our study employs a relatively more rigorous statistical approach, involving a head-to-head comparison of the two interventions and, therefore, minimizes heterogeneity between the treatment and control groups. Additionally, we excluded small, non-comparative observational studies likely to introduce bias. The results of our study, however, are congruent with the findings reported by Primiani et al [21].

Procedure time, like reperfusion status, appears to be a predictor of good functional outcomes [22]. Moreover, a longer duration of thrombectomy is an independent risk factor for sICH [23]. Multiple studies evaluating procedure duration report faster thrombectomy using aspiration than was observed with stent retrievers [9,16,24]. In contrast to most studies, the observational study by Nishi et al. concluded that aspiration thrombectomy resulted in longer procedural times [17]. This study appeared to have a significant influence on our meta-analysis; and its removal during the sensitivity analysis changed the results from non-significant to significantly in favor of aspiration. The difference can potentially be attributed to the relatively small sample size of this cohort or to differences in operator skill.

While the previous meta-analysis in this area reported a lower frequency of sICH in the aspiration thrombectomy group; in keeping with the recent COMPASS trial, our updated study found no significant differences in the incidences of adverse events in the two treatment groups [8,20]. We believe our analysis reinforces the significance of the COMPASS trial results [8].

Our study, limited by its exploratory nature, carries the inevitable bias associated with a study-level meta-analysis. Additionally, the results of this analysis were partially based on observational studies, which are relatively more susceptible to bias due to confounding.


In this study, we compared the safety and efficacy of aspiration thrombectomy versus stent retriever thrombectomy among 1453 AIS patients. Additionally, we performed a subgroup analysis to evaluate whether the type of study, location of occlusion, and age of patient influenced the results produced. We also compared the procedure time of both the treatments. Our study concludes that both aspiration and stent retriever thrombectomy have comparable efficacy in the management of AIS, allowing the operator to individualize the treatment choice to the needs of the patient. These results are congruent with RCTs in the area and serve to consolidate and increase confidence in their findings. Procedure time may potentially be reduced with the use of aspiration thrombectomy, and outcomes with each procedure may be age-dependent.


  1. Powers WJ, Rabinstein AA, Ackerson T, et al.: 2018 guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2018, 49:46-110. 10.1161/STR.0000000000000158
  2. Jankowitz B, Grandhi R, Horev A, Aghaebrahim A, Jadhav A, Linares G, Jovin T: Primary manual aspiration thrombectomy (MAT) for acute ischemic stroke: safety, feasibility and outcomes in 112 consecutive patients. J Neurointerv Surg. 2015, 7:27-31. 10.1136/neurintsurg-2013-011024
  3. Jankowitz B, Aghaebrahim A, Zirra A, et al.: Manual aspiration thrombectomy: adjunctive endovascular recanalization technique in acute stroke interventions. Stroke. 2012, 43:1408-1411. 10.1161/STROKEAHA.111.646117
  4. Comai A, Haglmuller T, Ferro F, Dall'Ora E, Currò Dossi R, Bonatti G: Sequential endovascular thrombectomy approach (SETA) to acute ischemic stroke: preliminary single-centre results and cost analysis. Radiol Med. 2015, 120:655-661. 10.1007/s11547-015-0501-9
  5. Lapergue B, Blanc R, Guedin P, et al.: A direct aspiration, first pass technique (ADAPT) versus stent retrievers for acute stroke therapy: an observational comparative study. AJNR Am J Neuroradiol. 2016, 1:1860-1865. 10.3174/ajnr.A4840
  6. Gerber JC, Daubner D, Kaiser D, et al.: Efficacy and safety of direct aspiration first pass technique versus stent-retriever thrombectomy in acute basilar artery occlusion—a retrospective single center experience. Neuroradiology. 2017, 1:297-304. 10.1007/s00234-017-1802-6
  7. Lapergue B, Blanc R, Gory B, et al.: Effect of endovascular contact aspiration vs stent retriever on revascularization in patients with acute ischemic stroke and large vessel occlusion. The ASTER randomized clinical trial. JAMA. 2017, 318:443-452. 10.1001/jama.2017.9644
  8. Turk AS 3rd, Siddiqui A, Fifi JT, et al.: Aspiration thrombectomy versus stent retriever thrombectomy as first-line approach for large vessel occlusion (COMPASS): a multicentre, randomised, open label, blinded outcome, non-inferiority trial. Lancet. 2019, 393:998-1008. 10.1016/S0140-6736(19)30297-1
  9. Stapleton CJ, Leslie-Mazwi TM, Torok CM, et al.: A direct aspiration first-pass technique vs stentriever thrombectomy in emergent large vessel intracranial occlusions. J Neurosurg. 2018, 1:567-574. 10.3171/2016.11.JNS161563
  10. Hutton B, Salanti G, Caldwell DM, et al.: The PRISMA extension statement for reporting of systematic reviews incorporating network meta-analyses of health care interventions: checklist and explanations. Ann Intern Med. 2015, 162:777-784. 10.7326/M14-2385
  11. The Cochrane Collaboration: Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0. Higgins JPT, Green S (ed): Cochrane, London, United Kingdom; 2011.
  12. Higgins JP, Altman DG, Gøtzsche PC, et al.: The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials. BMJ. 2011, 343:d5928. 10.1136/bmj.d5928
  13. The Newcastle-Ottawa scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. (2011). Accessed: January 23, 2020: http://www.evidencebasedpublichealth.de/download/Newcastle_Ottowa_Scale_Pope_Bruce.pdf.
  14. Mokin M, Primiani CT, Ren Z, et al.: Endovascular treatment of middle cerebral artery M2 occlusion strokes: clinical and procedural predictors of outcomes. Neurosurgery. 2017, 10:795-802. 10.1093/neuros/nyx060
  15. Mokin M, Sonig A, Sivakanthan S, et al.: Clinical and procedural predictors of outcomes from the endovascular treatment of posterior circulation strokes. Stroke. 2016, 47:782-788. 10.1161/STROKEAHA.115.011598
  16. Maegerlein C, Prothmann S, Lucia KE, Zimmer C, Friedrich B, Kaesmacher J: Intraprocedural thrombus fragmentation during interventional stroke treatment: a comparison of direct thrombus aspiration and stent retriever thrombectomy. Cardiovasc Intervent Radiol. 2017, 1:987-993. 10.1007/s00270-017-1614-4
  17. Nishi H, Ishii A, Nakahara I, et al.: Different learning curves between stent retrieval and a direct aspiration first-pass technique for acute ischemic stroke. J Neurosurg. 2018, 129:1456-1463. 10.3171/2017.6.JNS17872
  18. Higgins JP, Thompson SG, Deeks JJ, Altman DG: Measuring inconsistency in meta-analyses. BMJ. 2003, 327:557-560. 10.1136/bmj.327.7414.557
  19. Gascou G, Lobotesis K, Machi P, et al.: Stent retrievers in acute ischemic stroke: complications and failures during the perioperative period. AJNR Am J Neuroradiol. 2014, 1:734-740. 10.3174/ajnr.A3746
  20. Qin C, Shang K, Xu SB, Wang W, Zhang Q, Tian DS: Efficacy and safety of direct aspiration versus stent-retriever for recanalization in acute cerebral infarction: A PRISMA-compliant systematic review and meta-analysis. Medicine (Baltimore). 2018, 97:12770. 10.1097/MD.0000000000012770
  21. Primiani CT, Vicente AC, Brannick MT, et al.: Direct aspiration versus stent retriever thrombectomy for acute stroke: a systematic review and meta-analysis in 9127 patients. J Stroke Cerebrovasc Dis. 2019, 1:1329-1337. 10.1016/j.jstrokecerebrovasdis.2019.01.034
  22. Bouslama M, Haussen DC, Aghaebrahim A, et al.: Predictors of good outcome after endovascular therapy for vertebrobasilar occlusion stroke. Stroke. 2017, 48:3252-3257. 10.1161/STROKEAHA.117.018270
  23. Kass-Hout T, Kass-Hout O, Sun CJ, Kass-Hout TA, Nogueira R, Gupta R: Longer procedural times are independently associated with symptomatic intracranial hemorrhage in patients with large vessel occlusion stroke undergoing thrombectomy. J Neurointerv Surg. 2016, 8:1217-1220. 10.1136/neurintsurg-2015-012157
  24. Guzzardi G, Del Sette B, Stanca C, Galbiati A, Cernigliaro M, Carriero A, Stecco A: Mechanical thrombectomy by a direct aspiration first pass technique (ADAPT) in ischemic stroke: results of monocentric study based on multimodal CT patient selection. Stroke Res Treat. 2018, 2018:6192483. 10.1155/2018/6192483
Original article

Aspiration Thrombectomy Versus Stent Retriever Thrombectomy Alone for Acute Ischemic Stroke: A Systematic Review and Meta-Analysis

Author Information

Marium Zafar Corresponding Author

Internal Medicine, Dow Medical College, Pakistan, Karachi, PAK

Muhammad Mussa

Internal Medicine, Dow Medical College, Dow University of Health Sciences (DUHS), Karachi, PAK

Roha S. Memon

Internal Medicine, Dow University of Health Sciences (DUHS), Karachi, PAK

Shahrukh Nadeem

Medicine, Dow University of Health Sciences (DUHS), Karachi, PAK

Muhammad S. Usman

Internal Medicine, Civil Hospital Karachi, Dow University of Health Sciences (DUHS), Karachi, PAK

Javed Siddiqi

Neurosurgery, Desert Regional Medical Center, Palm Springs, USA

Neurosurgery, Riverside University Health System Medical Center, Moreno Valley, USA

Neurosurgery, Arrowhead Regional Medical Center, Colton, USA

Neurosurgery, California University of Science and Medicine, Colton, USA

Alexander Norbash

Radiology, Neuroradiology, Interventional Radiology, University of California, San Diego, USA

Faisal Khosa

Radiology, Vancouver General Hospital, University of British Columbia, Vancouver, CAN

Vincent M. Figueredo

Cardiovascular Diseases, Einstein Medical Center, Philadelphia, USA

Richard Krasuski

Cardiovascular Medicine, Duke University Health System, Durham, USA

Muhammad S. Khan

Internal Medicine, John H Stroger J. Hospital of Cook County, Chicago, USA

Ethics Statement and Conflict of Interest Disclosures

Human subjects: All authors have confirmed that this study did not involve human participants or tissue. Animal subjects: All authors have confirmed that this study did not involve animal subjects or tissue. Conflicts of interest: In compliance with the ICMJE uniform disclosure form, all authors declare the following: Payment/services info: All authors have declared that no financial support was received from any organization for the submitted work. Financial relationships: All authors have declared that they have no financial relationships at present or within the previous three years with any organizations that might have an interest in the submitted work. Other relationships: All authors have declared that there are no other relationships or activities that could appear to have influenced the submitted work.


Dr Alexander Norbash is the scientific advisor to Siemens, GE, Penumbra, and Stryker Stockholder and cofounder Boston Imaging Core Laboratories. Dr. Khosa is the recipient of the Young Investigator Award of the Canadian Association of Radiologists (2019).

Original article

Aspiration Thrombectomy Versus Stent Retriever Thrombectomy Alone for Acute Ischemic Stroke: A Systematic Review and Meta-Analysis

Figures etc.


Scholary Impact Quotient™ (SIQ™) is our unique post-publication peer review rating process. Learn more here.